Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 26;14(9):e29583.
doi: 10.7759/cureus.29583. eCollection 2022 Sep.

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment

Affiliations
Review

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment

Hrishikesh Vyawahare et al. Cureus. .

Abstract

The greatest global root of irremediable amaurosis in the venerable is age-related macular degeneration (AMD), a complex eye condition. Clinically, AMD is characterized as being in an early stage to late stage and initially affects the macula, which is the center of the retina (advanced AMD). Age-related cellular and metabolic imbalance are made worse by the creation of excessive amounts of free radical species, which causes mitochondrial malfunction. As a result, in AMD-affected eyes, the deprivation of melanocytes, confection, and eventually atrophy within the retinal tissue are caused by the continued proliferation of oxidative stress caused by systemic antioxidant capacity depletion. In the urbanized, industrialized world, age-related macular degeneration (AMD) is one of the major causes of central vision loss in the older age group. Although several causes and mechanisms for the dysfunction and degeneration of the retinal pigment epithelium (RPE) have previously been identified, the condition's symptoms are still not fully understood. Etiopathogenesis is still not entirely understood. As a result, the RPE fails, allowing an accumulation of aberrant misfolded proteins, due to the loss of anatomical control over oppression, altered homeostasis, dysfunctional lipid homeostasis, and failure of mitochondria. Due to the multitude of interconnected processes, numerous complicated therapy combinations will probably be the best option to deliver the best visual outcomes; these combinations will vary depending on the kind and degree of the condition being treated. Undoubtedly, this will lead to the development of customized preventative medications and, hopefully, the revelation of a potential cure. All the mechanisms involved in the etiology of AMD should be continuously probed to create covariates for other contemporaneous or future problems.

Keywords: age-related macular degeneration; homeostasis; neuroinflammation; oxidative stress; proteostasis; retinal pigment epithelium (rpe).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L. Genes Dis. 2022;9:62–79. - PMC - PubMed
    1. AI-based structure-function correlation in age-related macular degeneration. von der Emde L, Pfau M, Holz FG, et al. Eye (Lond) 2021;35:2110–2118. - PMC - PubMed
    1. Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options. Tan CS, Ngo WK, Chay IW, Ting DS, Sadda SR. Clin Ophthalmol. 2022;16:917–933. - PMC - PubMed
    1. Prevention of the onset of age-related macular degeneration. Di Carlo E, Augustin AJ. J Clin Med. 2021;10:3297. - PMC - PubMed
    1. Peripheral manifestations in age related macular degeneration: a review of imaging and findings. Pivovar A, Oellers P. J Clin Med. 2021;10 - PMC - PubMed

LinkOut - more resources